174 related articles for article (PubMed ID: 24407580)
1. Secondary leukemia after chemotherapy and/or radiotherapy for gynecologic neoplasia.
Shimada T; Saito T; Okadome M; Shimamoto K; Ariyoshi K; Eto T; Tomita Y; Kodama K
Int J Gynecol Cancer; 2014 Feb; 24(2):178-83. PubMed ID: 24407580
[TBL] [Abstract][Full Text] [Related]
2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
3. Risk of leukemia after platinum-based chemotherapy for ovarian cancer.
Travis LB; Holowaty EJ; Bergfeldt K; Lynch CF; Kohler BA; Wiklund T; Curtis RE; Hall P; Andersson M; Pukkala E; Sturgeon J; Stovall M
N Engl J Med; 1999 Feb; 340(5):351-7. PubMed ID: 9929525
[TBL] [Abstract][Full Text] [Related]
4. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.
Diamandidou E; Buzdar AU; Smith TL; Frye D; Witjaksono M; Hortobagyi GN
J Clin Oncol; 1996 Oct; 14(10):2722-30. PubMed ID: 8874333
[TBL] [Abstract][Full Text] [Related]
5. [Therapy-related acute leukemia: study of 23 pacients].
Motlló C; Sancho JM; García O; Granada I; Millá F; Ribera JM
Med Clin (Barc); 2011 Oct; 137(10):449-52. PubMed ID: 21696789
[TBL] [Abstract][Full Text] [Related]
6. Treatment-related cancers after gynecologic malignancy.
Tucker MA; Fraumeni JF
Cancer; 1987 Oct; 60(8 Suppl):2117-22. PubMed ID: 3308071
[TBL] [Abstract][Full Text] [Related]
7. Treatment of testicular cancer and the development of secondary malignancies.
Bokemeyer C; Schmoll HJ
J Clin Oncol; 1995 Jan; 13(1):283-92. PubMed ID: 7799032
[TBL] [Abstract][Full Text] [Related]
8. Gynecologic cancer treatment: risk factors for therapeutically induced neoplasia.
Messerschmidt GL; Hoover R; Young RC
Cancer; 1981 Jul; 48(2 Suppl):442-50. PubMed ID: 7023660
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT).
Arians N; Foerster R; Rom J; Uhl M; Roeder F; Debus J; Lindel K
Radiat Oncol; 2016 Mar; 11():44. PubMed ID: 26988089
[TBL] [Abstract][Full Text] [Related]
10. Secondary myelodysplastic syndromes and acute leukemias.
Zeidman A; Dayan DB; Mittelman M
Haematologia (Budap); 1995; 27(1):23-8. PubMed ID: 12051292
[TBL] [Abstract][Full Text] [Related]
11. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
12. Therapy related leukemias: susceptibility, prevention and treatment.
Leone G; Voso MT; Sica S; Morosetti R; Pagano L
Leuk Lymphoma; 2001 Apr; 41(3-4):255-76. PubMed ID: 11378539
[TBL] [Abstract][Full Text] [Related]
13. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
[TBL] [Abstract][Full Text] [Related]
14. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
Haase D; Hanf V; Schulz T
Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
[TBL] [Abstract][Full Text] [Related]
15. [Leukemias induced by anticancer chemotherapies].
Harousseau JL
Bull Cancer; 1999 Nov; 86(11):929-38. PubMed ID: 10586109
[TBL] [Abstract][Full Text] [Related]
16. [Second malignant disease in patients under treatment for malignant lymphoma].
Várady E; Molnár Z; Schneider T; Fleischmann T
Orv Hetil; 1995 Oct; 136(43):2323-8. PubMed ID: 7478476
[TBL] [Abstract][Full Text] [Related]
17. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract][Full Text] [Related]
18. Postirradiation sarcoma of the gynecologic tract. A report of 13 cases and a discussion of the risk of radiation-induced gynecologic malignancies.
Mark RJ; Poen J; Tran LM; Fu YS; Heaps J; Parker RG
Am J Clin Oncol; 1996 Feb; 19(1):59-64. PubMed ID: 8554038
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow transplantation for secondary leukemia or myelodysplasia.
Witherspoon RP; Deeg HJ
Haematologica; 1999 Dec; 84(12):1085-7. PubMed ID: 10586209
[TBL] [Abstract][Full Text] [Related]
20. Acute Myeloid Leukemia Following Gynecologic Cancer in the Era of Platinum-Based Chemotherapy.
Nasioudis D; Lontos K; Tsagianni A; Boyiadzis M; Ko EM
Int J Gynecol Cancer; 2018 Oct; 28(8):1639-1642. PubMed ID: 30095705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
